ENG/中
老虎证券
行情
交易
收费
下载
优惠与活动
帮助
TigerAI
机构
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
股权激励
关于
登录
立即注册
Toggle
澳股
详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务
IMRICOR MEDICAL SYSTEMS-CDI
1.990
-0.110
-5.24%
成交量:
21.84万
成交额:
43.69万
市值:
6.39亿
市盈率:
-10.04
高:
2.100
开:
2.100
低:
1.950
收:
2.100
52周最高:
2.250
52周最低:
1.115
股本:
3.21亿
流通股本:
2.75亿
量比:
1.08
换手率:
0.08%
股息:
- -
股息率:
- -
每股收益(TTM):
-0.198
每股收益(LYR):
-0.133
净资产收益率:
-432.29%
总资产收益率:
-38.22%
市净率:
19.54
市盈率(LYR):
-15.01
数据加载中...
总览
公司
新闻资讯
公告
IMRICOR MEDICAL SYSTEMS-CDI - UVA健康获得机构审查委员会批准,参与公司的Visabl-Afl临床试验
美股速递
·
2025/12/15
Imricor Medical Systems Inc成功完成FDA审批通道内所有设备的人因工程研究
美股速递
·
2025/09/18
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券 | 轻松买卖美股港股A股/美债/ETF/Crypto/期权期货","description":"老虎证券提供多项优惠: 港股&Crypto 0佣0平台费、A股通一年免佣、美股期权0佣、IPO打新0融资利息0手续费。 美股1美元起投,免费实时行情与多种工具,立即开户享更多优惠!","keywords":"老虎证券,老虎证券开户,老虎证券香港,老虎证券登录,老虎证券官网,香港证券开户,证券公司开户,股票开户,香港证券公司,香港证券,证券公司,股票投资,投资app,投资平台,股票买卖,股票交易平台,股票app,证券app,新手投资","social":{"ogDescription":"老虎证券提供多项优惠: 港股&Crypto 0佣0平台费、A股通一年免佣、美股期权0佣、IPO打新0融资利息0手续费。 美股1美元起投,免费实时行情与多种工具,立即开户享更多优惠!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/IMR.AU/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"IMR.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"IMR.AU\",,,,,undefined,":{"symbol":"IMR.AU","market":"AU","secType":"STK","nameCN":"IMRICOR MEDICAL SYSTEMS-CDI","latestPrice":1.99,"timestamp":1771909920000,"preClose":2.1,"halted":0,"volume":218446,"delay":0,"changeRate":-0.052380952380952424,"nameEN":"IMRICOR MEDICAL SYSTEMS-CDI","floatShares":275046474,"shares":320947028,"eps":-0.198135,"marketStatus":"未开盘","change":-0.11,"latestTime":"02-24 16:12:00 AEDT","open":2.1,"high":2.1,"low":1.95,"amount":436940,"amplitude":0.071429,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.198135,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":0,"beginTime":1771974000000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":2.1,"openAndCloseTimeList":[[1771887600000,1771909200000]],"volumeRatio":1.0826303163354751,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"IMR.AU\",,,,,undefined,":{"symbol":"IMR.AU","floatShares":275046474,"roa":"-38.22%","roe":"-432.29%","lyrEps":-0.132557,"volumeRatio":1.0826303163354751,"shares":320947028,"dividePrice":0,"high":2.1,"amplitude":0.071429,"preClose":2.1,"low":1.95,"week52Low":1.115,"pbRate":"19.54","psRate":"602.53","week52High":2.25,"institutionHeld":0,"latestPrice":1.99,"eps":-0.198135,"divideRate":0,"volume":218446,"delay":0,"ttmEps":-0.198135,"open":2.1,"prevYearClose":1.53,"prevWeekClose":2.17,"prevMonthClose":1.98,"prevQuarterClose":1.53,"fiveDayClose":2.04,"twentyDayClose":1.9,"sixtyDayClose":1.49,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IMR.AU\",params:#limit:5,,,undefined,":[{"date":"2026-02-24","symbol":"IMR.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1771887600000,"name":null,"time":"","dateTimestamp":1771851600000,"actualEps":null},{"date":"2025-08-26","symbol":"IMR.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756166400000,"name":null,"time":"","dateTimestamp":1756130400000,"actualEps":null},{"date":"2025-02-26","symbol":"IMR.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1740524400000,"name":null,"time":"","dateTimestamp":1740488400000,"actualEps":null},{"date":"2024-08-28","symbol":"IMR.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724803200000,"name":null,"time":"","dateTimestamp":1724767200000,"actualEps":null},{"date":"2024-04-30","symbol":"IMR.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1714435200000,"name":null,"time":"","dateTimestamp":1714399200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IMR.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IMR.AU\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1104146213","title":"IMRICOR MEDICAL SYSTEMS-CDI - UVA健康获得机构审查委员会批准,参与公司的Visabl-Afl临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=1104146213","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1104146213?lang=zh_cn&edition=fundamental","pubTime":"2025-12-15 05:26","pubTimestamp":1765747570,"startTime":"0","endTime":"0","summary":"IMRICOR MEDICAL SYSTEMS-CDI - UVA健康获得机构审查委员会批准,参与公司的Visabl-Afl临床试验。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7007","IMR.AU","BK7503","BK7508"],"gpt_icon":0},{"id":"1199473456","title":"Imricor Medical Systems Inc成功完成FDA审批通道内所有设备的人因工程研究","url":"https://stock-news.laohu8.com/highlight/detail?id=1199473456","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199473456?lang=zh_cn&edition=fundamental","pubTime":"2025-09-18 06:55","pubTimestamp":1758149714,"startTime":"0","endTime":"0","summary":"Imricor Medical Systems Inc宣布已成功完成其FDA审批通道内所有医疗设备的人因工程研究。\n该项研究的顺利完成标志着公司在获得美国食品药品监督管理局(FDA)批准方面迈出了重要一步,为其医疗设备产品的商业化进程奠定了坚实基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMR.AU","BK7508","BK7007","BK7503"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":2,"code":"91000000","status":"200"}]}}